Admission Date:  [**2189-5-28**]              Discharge Date:   [**2189-5-30**]   Service: MEDICINE  Allergies: Penicillins  Attending:[**First Name3 (LF) 1973**] Chief Complaint: hemoptysis during CT-guided placement of fiducial by interventional radiology   Major Surgical or Invasive Procedure: CT-guided placement of fiducial by interventional radiology   History of Present Illness: 87 yo F with history of HTN, lung adenocarcinoma who was admitted after hemoptysis during an IR procedure.
On day of admission, pt visited interventional radiology for a fiducial seed placement for upcoming cyberknife therapy.
[**3-18**] flex bronch, cevical mediastinscopy, left VATs, evacuation of pleural effusion, LN all negative but LUL lung nodule PET(+)) Hypertension TKR, right [**8-23**] TAH Cholecystectomy [**2183**]   Social History: Patient smoked for 30 years, started age 18.
She lives alone in Fishkill, NY, and drove to [**Location (un) 86**] w/ her daughter for treatment of the lung cancer.
Gait assessment deferred PSYCH: Listens and responds to questions appropriately, pleasant   Pertinent Results: LABS [**2189-5-28**] 08:00AM WBC-3.7* RBC-3.64* Hgb-12.0 Hct-34.7* MCV-95 MCH-32.9* MCHC-34.5 RDW-14.0 Plt Ct-305 [**2189-5-28**] 01:32PM WBC-5.9# RBC-3.24* Hgb-10.8* Hct-31.5* MCV-97 MCH-33.3* MCHC-34.2 RDW-13.5 Plt Ct-274 [**2189-5-28**] 09:14PM Hct-30.7* [**2189-5-29**] 05:32AM WBC-3.9* RBC-2.89* Hgb-9.8* Hct-27.6* MCV-96 MCH-34.1* MCHC-35.7* RDW-14.1 Plt Ct-244 [**2189-5-29**] 06:55PM Hct-30.2* [**2189-5-30**] 06:40AM WBC-3.0* RBC-3.07* Hgb-10.3* Hct-29.1* MCV-95 MCH-33.6* MCHC-35.5* RDW-13.9 Plt Ct-270  [**2189-5-28**] 01:32PM BLOOD Glucose-108* UreaN-21* Creat-0.9 Na-142 K-3.9 Cl-103 HCO3-28 AnGap-15 [**2189-5-30**] 06:40AM BLOOD Glucose-91 UreaN-20 Creat-0.9 Na-141 K-3.9 Cl-103 HCO3-29 AnGap-13  CYTOLOGY [**2189-6-1**] SPECIMEN RECEIVED: [**2189-5-28**] CYTOPATHOLOGY SMEARS, NON-GYN Touch prep of core, lung, left upper lobe: Positive for malignant cells, consistent with adenocarcinoma.
TRACING #1 Read by:	[**Last Name (LF) **],[**First Name3 (LF) **] S.  	Intervals	Axes Rate	PR	QRS	QT/QTc	P	QRS	T 125	146	86	298/411	-122	53	-102  IMAGING STUDIES CT INTERVENTIONAL PROCEDURE, LEFT UPPER LOBE LUNG NODULE BIOPSY UNDER CT FLUOROSCOPIC GUIDANCE [**2189-5-28**] IMPRESSION: Core biopsy of the left upper lobe speculated mass.Planned fiducial seed placement could not be performed due to hemopysis and deterioration in patient condition.
She was rate controlled with diltiazem and spontaneously converted.
After 10mg IV diltiazem patient's HR decreased to high 60s, then remained in high 50s-mid 60s on the afternoon/night of [**5-28**].
She was continued on her home diltiazem 240mg QD and HCTZ 50mg QD.
She was given a 500mL NS bolus and Cr was followed.
Diltiazem HCl 120 mg Capsule, Sustained Release Sig: Two (2) Capsule, Sustained Release PO DAILY (Daily).
Multivitamin     Tablet Sig: One (1) Cap PO DAILY (Daily).
Hydrochlorothiazide 12.5 mg Capsule Sig: One (1) Capsule PO DAILY (Daily).
Ferrous Gluconate 325 mg (37.5 mg Iron) Tablet Sig: One (1) Tablet PO DAILY (Daily).
Discharge Instructions: You were admitted for a procedure to prepare for cyberknife therapy for your lung cancer.
The procedure was complicated by blood loss and hemoptysis (coughing up blood).
Your blood count (hematocrit) did decrease following the procedure you underwent.
Prior to the procedure your hematocrit was 34 and following the procedure it was 30.
You should also continue taking your iron pills.
If you develop any shortness of breath, chest pain, abdominal pain, blood in your stools, nausea, vomiting, fever, chills, palpitations, or any other concerning symptoms, please call your primary care physician or immediately proceed to the emergency department at the nearest hospital.
